APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Enhancing Oligonucleotide Immunomodulatory Activity through Dianophore Long-Lasting Modification: Methods and Applications

COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS

DOUBLE STRANDED RNAi AGENTS, COMPOSITIONS AND METHODS OF USE

PLIN1 RNAi INTERFERENCE AGENTS

RNAi Agent Targeting PCSK9 and Use Thereof

NANOCOMPLEX TARGETING NERVOUS NECROSIS VIRUS AS WELL AS PREPARATION METHOD AND USE THEREOF

COMPOSITIONS AND METHODS FOR DELIVERING A MACROMOLECULE TO A CELL

RNA THERAPEUTICS FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA AND USES THEREOF

CHEMICAL MODIFICATIONS OF SMALL INTERFERING RNA WITH MINIMAL FLUORINE CONTENT

DOUBLE-STRANDED RNAi AGENTS FOR TARGETING AND REGULATING HBV GENE EXPRESSION, AND A USE THEREOF

OLIGONUCLEOTIDES CONJUGATED TO OLEIC ACID AND USES THEREOF

OLIGONUCLEOTIDES FOR MAPT MODULATION

POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF

PKC INHIBITORS FOR THE TREATMENT OF SEPTIC CHOLESTASIS WITH POLYMETHINE DYE TARGETING

MODIFIED DOUBLE-STRANDED RNA AGENTS

ANTI-C5 ANTIBODY/C5 IRNA DOSING REGIMENS FOR TREATING C5-ASSOCIATED DISEASES

COMPOSITIONS AND METHODS FOR THE TREATMENT OF COMPLICATIONS AND DISORDERS RELATING TO VON WILLEBRAND FACTOR

METHODS FOR TREATMENT OF ANEMIA

DOUBLE-STRANDED RNAI AGENTS AND COMPOSITIONS FOR REDUCING EXPRESSION OF ANGIOPOIETIN-LIKE 3 (ANGPTL3) AND METHODS OF USE THEREOF

Carbohydrate-oligonucleotide conjugates, pharmaceutical compositions, and therapeutic applications

PRODUCTS AND COMPOSITIONS

GALNAC MONOMER COMPRISING RIBOSE RING OR DERIVATIVE STRUCTURE THEREOF AND USE THEREOF IN LIVER-TARGETED DELIVERY OF SMALL NUCLEIC ACID DRUGS

SIRNA FOR TARGETED INHIBITION OF AGT GENE EXPRESSION AND USE THEREOF IN TREATING HYPERTENSION

CONJUGATED OLIGONUCLEOTIDE COMPOUNDS, METHODS OF MAKING AND USES THEREOF

Methods for Directing Lipid Nanoparticles in Vivo

RNAi Agents for Inhibiting Influenza A Viral Gene Expression, Compositions Thereof, and Methods of Use

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL

OLIGONUCLEOTIDES, COMPOSITIONS AND METHODS THEREOF

CONJUGATE OF NUCLEOTIDE ANALOG-CONTAINING DOUBLE-STRANDED RNAI ANALOG

COMPOSITIONS AND METHODS FOR INHIBITING LPA EXPRESSION

Oral Delivery of Antisense Conjugates Targeting PCSK9

GalNAc conjugated oligonucleotides for RNA editing

ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING XDH EXPRESSION

REVERSIR MOLECULES AND METHODS OF USE THEREOF

SIRNA TARGETING ANGPTL4, AND CONJUGATES AND USES THEREOF

TREATMENT OF MST1 RELATED DISEASES AND DISORDERS

COMPOSITIONS AND METHODS FOR TREATING NONALCOHOLIC FATTY LIVER DISEASE

GalNAc Compound Containing Triazole Structure and Oligonucleotide Conjugate Thereof

METHOD FOR REDUCING THE RISK OF A CARDIOVASCULAR EVENT WITH CONJUGATED ANTISENSE COMPOUNDS TARGETING APO(A)

RNAi Agents for Inhibiting Expression of Thymic Stromal Lymphopoietin (TSLP), Compositions Thereof, and Methods of Use

RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3)

Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon Skipping

PLASMINOGEN (PLG) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR TARGETING SERINE DEHYDRATASE

COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF INHIBIN SUBUNIT BETA E (INHBE) GENES

COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION

KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF INHIBIN SUBUNIT BETA E (INHBE) GENES

Compositions and Methods for Modulating Complement Factor B Expression

RNAi Agents for Inhibiting Expression of Complement Factor B (CFB), Pharmaceutical Compositions Thereof, and Methods of Use

Optimized RNAi Agents for Inhibiting Expression of Coronavirus (CoV) Viral Genomes, Compositions Thereof, and Methods of Use

RNAI AGENTS FOR INHIBITING EXPRESSION OF HUNTINGTIN (HTT), COMPOSITIONS THEREOF, AND METHODS OF USE

1'-ALKYL MODIFIED RIBOSE DERIVATIVES AND METHODS OF USE

DOUBLE STRANDED RNAi AGENTS, COMPOSITIONS AND METHODS OF USE

RNAi Agents for Inhibiting Expression of Mitochondrial Amidoxime Reducing Component 1 (MARC1), Pharmaceutical Compositions Thereof, and Methods of Use

INHIBITORS OF EXPRESSION AND/OR FUNCTION

GALNAC COMPOUND CONTAINING RIBOSE RING OR ITS DERIVATIVE STRUCTURE AND OLIGONUCLEOTIDE CONJUGATE THEREOF

ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES

COMPOUND FOR INHIBITING AGT GENE EXPRESSION, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

COMPOUND FOR INHIBITING EXPRESSION OF LPA GENE, PHARMACEUTICAL COMPOSITION AND USE THEREOF

OLIGONUCLEOTIDES FOR MODULATING RTEL1 EXPRESSION

SIRNA TARGETING AND REGULATING PCSK9 GENE EXPRESSION AND USE THEREOF

COMPOUNDS AND METHODS FOR REDUCING PRION EXPRESSION

TETRAZINE-DERIVED LINKERS FOR SINGLE GUIDE RNAS

OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION

ADVANCED RNA TARGETING (ARNATAR)

NUCLEIC ACID COMPOUNDS

CANCER THERAPY WITH TGF-BETA-2 AND IRINOTECAN AGENTS

DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS FOR RNA INTERFERENCE AND METHODS RELATING THERETO

SMALL INTERFERING RNA TARGETING CFB AND USES THEREOF

NOVEL RNA THERAPEUTICS AND USES THEREOF

RNA-EDITING OLIGONUCLEOTIDES AND USES THEREOF

RNAi Agents for Inhibiting Expression of Proprotein Convertase Subtilisin Kexin 9 (PCSK9), Pharmaceutical Compositions Thereof, and Methods of Use

THREOSE NUCLEIC ACID ANTISENSE OLIGONUCLEOTIDES AND METHODS THEREOF

Selective Antisense Compounds and Uses Thereof

NUCLEIC ACID COMPOUNDS

METHODS AND COMPOSITIONS FOR INHIBITION OF IRF4

MODIFIED ANTISENSE OLIGONUCLEOTIDES FOR TREATING HEPATITIS B VIRUS

Linkage Modified Oligomeric Compounds and Uses Thereof

NUCLEIC ACID COMPOUNDS

TREATMENT OF MS4A4E RELATED DISEASES AND DISORDERS

POLYNUCLEIC ACID MOLECULES TARGETING AGT AND USES THEREOF

DUAL-ACTING siRNA BASED MODULATION OF C9orf72

CALCIUM SALTED SPHERICAL NUCLEIC ACIDS

Ligand-Modified Oligonucleotides

RNAI AGENT INHIBITING PCSK9 GENE EXPRESSION AND APPLICATION THEREOF

CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

Linkage Modified Oligomeric Compounds and Uses Thereof

GENETIC SEQUENCE-CARBOHYDRATE CONJUGATES FOR ENHANCED LIVER- AND KIDNEY-SPECIFIC TARGETING

RNAi Agents for Inhibiting Expression of Complement Component C3 (C3), Pharmaceutical Compositions Thereof, and Methods of Use

Conjugated Antisense Compounds and Their Use

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

POLYNUCLEIC ACID MOLECULES FOR INHIBITING EXPRESSION OF ANGPTL3, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

RNAi Agents for Inhibiting Expression of Complement Component C3 (C3), Pharmaceutical Compositions Thereof, and Methods of Use

SIRNA FOR INHIBITING ANGPTL3 GENE EXPRESSION AND USE THEREOF

Targeting Skin-Related Conditions Using Bottlebrush Polymer-Conjugated Oligonucleotides

LPA-TARGETING SIRNA AND CONJUGATE

CHEMICALLY MODIFIED ANTISENSE OLIGONUCLEOTIDES (ASOS) AND COMPOSITIONS FOR RNA EDITING

ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF

SUSTAINED RELEASE NUCLEIC ACID FORMULATIONS FOR TREATMENT OF PERIPHERAL NERVE DEMYELINATION

COMPOSITIONS AND METHODS FOR INHIBITING COMPLEMENT FACTOR B

APTAMER, CONJUGATE, COMPOSITION, METHOD FOR PREPARING SAME, AND USE THEREOF

Compounds and Methods for Reducing KCNT1 Expression

NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND SIRNA CONJUGATE CONTAINING THE NUCLEIC ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF

COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS (HBV) INFECTION AND HBV-ASSOCIATED DISEASES

MODULATION OF ABCB11 GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNAS

INHIBITORS OF EXPRESSION AND/OR FUNCTION

NUCLEIC ACID MOLECULE FOR REDUCTION OF PAPD5 AND PAPD7 mRNA FOR TREATING HEPATITIS B INFECTION

ENGINEERED CIRCULARIZED pegRNAs AND USES THEREOF

PRODUCTS AND COMPOSITIONS

INTERFERING RNA FOR INHIBITING PCSK9 GENE EXPRESSION AND USE THEREOF

METHODS FOR TREATING HYPERCHOLESTEROLEMIA

TREATMENT OF MST1 RELATED DISEASES AND DISORDERS

PRODUCTS AND COMPOSITIONS

RNAI CONSTRUCTS FOR INHIBITING SCAP EXPRESSION AND METHODS OF USE THEREOF

BASE EDITING OF TRANSTHYRETIN GENE

INHIBITORS OF EXPRESSION AND/OR FUNCTION

17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

EDITING OLIGONUCLEOTIDE

COMPOSITION AND METHOD FOR INHIBITING EXPRESSION OF PROTEIN LPA(APO(A))

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

COMPOSITIONS AND METHODS OF MODULATING XANTHINE DEHYDROGENASE

CHEMICALLY MODIFIED ANTISENSE OLIGONUCLEOTIDES (ASOS) AND COMPOSITIONS COMPRISING THE SAME FOR RNA EDITING

METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF LDHA

Oligonucleotide Terminal Phosphate Derivatives and Method of Use

ACTIN-BINDING LIM PROTEIN 3 (ABLIM3) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

LPA inhibitors and uses thereof

BIS-RNAI COMPOUNDS FOR CNS DELIVERY

COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION

Cyclic Structured Oligonucleotides as Therapeutic Agents

CONJUGATE, PHARMACEUTICAL COMPOSITION COMPRISING SAME, METHOD FOR PREPARING SAME, AND USE THEREOF

Olfactory Delivery Scaffolds Using Antisense Oligonucleotides and Methods for Making and Using Same

PHARMACEUTICAL COMBINATIONS FOR TREATMENT OF HBV

NUCLEIC ACID-POLYPEPTIDE NANO-PHARMACEUTICAL COMPOSTION FOR TREATING AND PREVENTING HUMAN PAPILLOMA VIRUS INFECTION

Linkage Modified Oligomeric Compounds

RNAI AGENTS TARGETING CIDEB AND RELATED METHODS

COMPOSITIONS AND METHODS FOR MODULATING APOC3 EXPRESSION

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASES WITH siRNAS TARGETING TBX3

CONJUGATED COMPOSITION AND METHOD FOR DELIVERING A THERAPEUTIC NUCLEIC ACID SEQUENCE TO A LIVING CELL

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASES WITH SIRNAS TARGETING SMYD2

OLIGONUCLEOTIDE INTERFERENCE TREATMENTS OF PROSTATE CANCER

KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITION AND METHOD FOR INHIBITING EXPRESSION OF PROTEIN LPA(APO(A))

SIGNAL ACTIVATABLE NUCLEIC ACID COMPLEXES

REVERSIR TM COMPOUNDS

MODULATION OF GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNAS

SIRNA OR SALT THEREOF AND MEDICAMENT FOR INHIBITING EXPRESSION OF TMPRSS6 GENE, AND USE THEREOF

POLYNUCLEIC ACID MOLECULES FOR INHIBITING EXPRESSION OF FXI, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

XANTHINE DEHYDROGENASE (XDH) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

PNPLA3-TARGETING SHORT INTERFERING RNA (SIRNA) MOLECULES AND USES THEREOF

UNIVERSAL NON-TARGETING SIRNA COMPOSITIONS AND METHODS OF USE THEREOF

OVERSUBSCRIPTION SCHEDULING

Compounds and Methods for Reducing APOCIII Expression

Targeting Ligands For Therapeutic Compounds

GLYCAN CONJUGATE COMPOSITIONS AND METHODS

MULTI-TARGETED SINGLE ENTITY CONJUGATES

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASES WITH SIRNAS TARGETING CIDEB

Nucleic acids for inhibiting expression of MASP-2 in a cell

Methods For The Treatment Of ANGPTL3-Related Diseases And Disorders

INTRACELLULAR TARGETING OF OLIGONUCLEOTIDES

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASES WITH SIRNAS TARGETING GPAM

PREPARATION AND ANTI-TUMOR APPLICATION OF GENE THERAPY VECTOR INTERFERING CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING PROTEIN 6 (CMTM6) EXPRESSION

MODIFIED DOUBLE-STRANDED OLIGONUCLEOTIDE MOLECULE, MODIFIED DOUBLE-STRANDED OLIGONUCLEOTIDE CONJUGATE, AND USE THEREOF

OLIGONUCLEOTIDES WITH 2'-DEOXY-2'-F-2'-C-METHYL NUCLEOTIDES

RNAi Agents for Inhibiting Expression of Complement Factor B (CFB), Pharmaceutical Compositions Thereof, and Methods of Use

SINGLE-STRAND FORM POLYNUCLEOTIDE AND USE THEREOF IN GENOME EDITING

BICYCLIC HETEROCYCLES AND THEIR LIGANDS FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS

AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTING AND TREATING FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES, COMPRISING SAME

ANTI-C5 AGENT FOR TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION (AMD) OR GEOGRAPHIC ATROPHY SECONDARY TO DRY AMD

MODIFIED RNA AGENTS WITH REDUCED OFF-TARGET EFFECT

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANGIOPOIETIN LIKE 7 (ANGPTL7) RELATED DISEASES

SIRNA TARGETING ANGIOTENSINOGEN AND PHARMACEUTICAL USE OF SIRNA

siRNA SUPPRESSING EXPRESSION OF TRANSFERRIN RECEPTOR 2

CHEMICALLY MODIFIED OLIGONUCLEOTIDE HAVING RNAi ACTIVITY

MULTIPLEXING TARGETING LIGANDS THROUGH CLICK CHEMISTRY AT THE ANOMERIC SITE OF SUGARS

POLYNUCLEIC ACID MOLECULES TARGETING APOC3 AND USES THEREOF

POLYNUCLEIC ACID MOLECULES FOR INHIBITING EXPRESSION OF LP(A), PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF

HIGH MOBILITY GROUP BOX-1 (HMGB1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

BLOCK COPOLYMERS

RNAI AGENT TARGETING MARC1 GENE, AND USE THEREOF

ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES

COMPOSITIONS OF MODIFIED TREMS AND USES THEREOF

ATXN2 RNA INTERFERENCE AGENTS

COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION

ANTISENSE OLIGOMERS AND METHODS OF USING THE SAME FOR TREATING DISEASES ASSOCIATED WITH THE ACID ALPHA-GLUCOSIDASE GENE

Brush polymer-oligonucleotide conjugates for the treatment of muscular dystrophy

COMPOSITIONS AND METHODS FOR IMPROVING STRAND BIASED

Therapeutic Inhibition of LPA Expression

COMPOSITION FOR PREVENTION OR TREATMENT OF LIVER CANCER, COMPRISING MODIFIED RT-LET7 AS ACTIVE INGREDIENT

GUIDE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING IN THE TREATMENT OF HYPERCHOLESTEROLEMIA

Compositions and Methods for Enhancing AAV Therapy and Decreasing Tropism of AAV to the Liver

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF PREKALLIKREIN (PKK) PROTEIN

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION

ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF

iRNA Compositions and Methods for Silencing ANGPTL4

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF COMPLEMENT FACTOR B (CFB) IN A CELL

Targeting Oncogenic KRAS with Molecular Brush-Conjugated Antisense Oligonucleotide

DENDRIMER CONJUGATES OF SMALL MOLECULE BIOLOGICS FOR INTRACELLULAR DELIVERY

NANOPARTICLE VECTOR FOR RNA SELF-DELIVERY, AND PREPARATION METHOD THEREFOR AND USE THEREOF

COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

COMBINATIONS WITH MODULATORS OF PNPLA3 EXPRESSION

METHODS OF PRODUCING CELLS RESISTANT TO HIV INFECTION

OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION

COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF LPA

COMPOUNDS AND METHODS FOR MODULATING PROGRANULIN EXPRESSION

DEGRADATION OF RNA BY THE LYSOSOMAL PATHWAY

ADVANCED RNA TARGETING (ARNATAR)

TARGETED COMPOSITIONS

COMPOSITIONS AND METHODS FOR INHIBITING KETOHEXOKINASE (KHK)

Modified Oligonucleotides and Methods of Use

Trialkyne Linking Agents and Methods of Use

TARGETING OF XKR8 IN THERAPIES

NONVIRAL VECTORS FOR GENE THERAPY

COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND TARGETED SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS

SELECTIVELY CONTROLLABLE CLEAVABLE LINKERS

TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES

RNAS FOR COMPLEMENT INHIBITION

OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION

PREKALLIKREIN-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF

AGT Inhibitor and Use Thereof

Advanced RNA targeting (ARNATAR) for angiotensinogen

ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION

CELL DEATH-INDUCING DFFA-LIKE EFFECTOR B (CIDEB) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING NUCLEIC ACID, PREPARATION METHOD THEREFOR AND USE THEREOF

OLIGONUCLEOTIDES FOR MODULATING TAU EXPRESSION

MULTIVALENT CARGO-CARRYING COMPLEXES AND USES THEREOF

iRNA Compositions and Methods for Silencing MYLIP

TREATMENT OF NEUROLOGICAL DISEASES USING MODULATORS OF UNC13A GENE TRANSCRIPTS

PRODUCTS AND COMPOSITIONS

TREATMENT OF FGG RELATED DISEASES AND DISORDERS

SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

RNAi Agents for Inhibiting Expression of PNPLA3, Pharmaceutical Compositions Thereof, and Methods of Use

Double Stranded Oligonucleotide For Modulating JAK1 Expression

OLIGONUCLEOTIDES FOR DGAT2, FASN, OPN, AND NOX4 MODULATIONS

MODIFIED DOUBLE-STRANDED RNA AGENTS

STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

CELL DEATH-INDUCING DFFA-LIKE EFFECTOR B (CIDEB) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

GLYCAN CONJUGATE COMPOSITIONS AND METHODS

Novel Compositions for Conjugating Oligonucleotides and Carbohydrates

DOUBLE STRANDED RNA TARGETING PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) AND METHODS OF USE THEREOF

STAGGERED TRIPLE LIPID-MODIFIED NUCLEIC ACID COMPOUNDS

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF TMPRSS6 AND IRON CHELATORS

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

IRNA COMPOSITIONS AND METHODS FOR SILENCING COMPLEMENT COMPONENT 3 (C3)

Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof

COMPOSITIONS AND METHODS FOR ENHANCING GENE SILENCING ACTIVITY OF OLIGONUCLEOTIDE COMPOUNDS

SPHERICAL NUCLEIC ACIDS FOR cGAS-STING AND STAT3 PATHWAY MODULATION FOR THE IMMUNOTHERAPEUTIC TREATMENT OF CANCER

NUCLEIC ACIDS CONTAINING ABASIC NUCLEOSIDES

TREATMENT OF COMPLEMENT-MEDIATED DISORDERS

COMPOSITIONS AND METHODS FOR INHIBITING COMPLEMENT COMPONENT 3 EXPRESSION

METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS

OLIGONUCLEOTIDES FOR SARS-CoV-2 MODULATION

PHARMACEUTICAL COMBINATIONS FOR TREATMENT OF HBV

KISSPEPTIN 1 (KISS1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

MODIFIED DOUBLE-STRANDED RNA AGENTS

Atg8ylation coordinates stress granule formation and mTOR inactivation in response to lysosomal damage

TRANSTHYRETIN (TTR) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

INTEGRIN TARGETING LIGANDS FOR OCULAR DELIVERY OF RNAI COMPOUNDS

FACTOR XII (F12) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR MODULATING PKK EXPRESSION

Compositions and methods for inhibiting LPA expression

ANGIOTENSINOGEN-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF

Compounds and Methods for Reducing ATXN2 Expression

COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION

METHODS AND COMPOSITIONS FOR HIGH-THROUGHPUT PROTEIN DELIVERY, SCREENING, AND DETECTION

TREATMENT OF MST1R RELATED DISEASES AND DISORDERS

Treatment of MST1 related diseases and disorders

TREATMENT OF MST1 RELATED DISEASES AND DISORDERS

IRNA COMPOSITIONS AND METHODS FOR SILENCING ANGIOTENSINOGEN (AGT)

COMPOSITIONS AND METHODS FOR MODULATING KRAS EXPRESSION

LIGAND CONJUGATES FOR DELIVERY OF THERAPEUTICALLY ACTIVE AGENTS

GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF USHER SYNDROME TYPE 3

COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Selective Antisense Compounds and Uses Thereof

EXTRA-HEPATIC DELIVERY IRNA COMPOSITIONS AND METHODS OF USE THEREOF

MODULATION OF GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNAS

DENDRITIC CONJUGATES FOR THE BRAIN DELIVERY OF THERAPEUTIC OLIGONUCLEOTIDES

CONJUGATE

DOUBLE STRANDED NUCLEIC ACID COMPOUNDS INHIBITING ZPI

Compositions and methods for modulating apolipoprotein (a) expression

PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

TREATMENT FOR TYROSINE DEGRADATION-ASSOCIATED DISORDERS

METHODS AND COMPOSITIONS FOR TREATING SUBJECTS HAVING OR AT RISK OF DEVELOPING A NON-PRIMARY HYPEROXALURIA DISEASE OR DISORDER

METHOD

COMPOSITIONS AND METHODS FOR INHIBITING LPA EXPRESSION

Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAs

INHIBITORS OF EXPRESSION AND/OR FUNCTION

USE OF OLIGONUCLEOTIDES FOR INDIVIDUALS WITH RENAL IMPAIRMENT

2'-MODIFIED NUCLEOSIDE BASED OLIGONUCLEOTIDE PRODRUGS

COMPOSITIONS AND METHODS FOR RNA AFFINITY